Immune Response to Biofilm Growing Pulmonary Pseudomonas aeruginosa Infection

Research output: Contribution to journalReviewResearchpeer-review

Standard

Immune Response to Biofilm Growing Pulmonary Pseudomonas aeruginosa Infection. / Thomsen, Kim; Høiby, Niels; Jensen, Peter Østrup; Ciofu, Oana; Moser, Claus.

In: Biomedicines, Vol. 10, No. 9, 2064, 2022.

Research output: Contribution to journalReviewResearchpeer-review

Harvard

Thomsen, K, Høiby, N, Jensen, PØ, Ciofu, O & Moser, C 2022, 'Immune Response to Biofilm Growing Pulmonary Pseudomonas aeruginosa Infection', Biomedicines, vol. 10, no. 9, 2064. https://doi.org/10.3390/biomedicines10092064

APA

Thomsen, K., Høiby, N., Jensen, P. Ø., Ciofu, O., & Moser, C. (2022). Immune Response to Biofilm Growing Pulmonary Pseudomonas aeruginosa Infection. Biomedicines, 10(9), [2064]. https://doi.org/10.3390/biomedicines10092064

Vancouver

Thomsen K, Høiby N, Jensen PØ, Ciofu O, Moser C. Immune Response to Biofilm Growing Pulmonary Pseudomonas aeruginosa Infection. Biomedicines. 2022;10(9). 2064. https://doi.org/10.3390/biomedicines10092064

Author

Thomsen, Kim ; Høiby, Niels ; Jensen, Peter Østrup ; Ciofu, Oana ; Moser, Claus. / Immune Response to Biofilm Growing Pulmonary Pseudomonas aeruginosa Infection. In: Biomedicines. 2022 ; Vol. 10, No. 9.

Bibtex

@article{3735ed18f17e4ae1a92392f845874914,
title = "Immune Response to Biofilm Growing Pulmonary Pseudomonas aeruginosa Infection",
abstract = "Biofilm infections are tolerant to the host responses and recalcitrance to antibiotic drugs and disinfectants. The induced host-specific innate and adaptive immune responses by established biofilms are significantly implicated and contributes to the course of the infections. Essentially, the host response may be the single one factor impacting the outcome most, especially in cases where the biofilm is caused by low virulent opportunistic bacterial species. Due to the chronicity of biofilm infections, activation of the adaptive immune response mechanisms is frequently experienced, and instead of clearing the infection, the adaptive response adds to the pathogenesis. To a high degree, this has been reported for chronic Pseudomonas aeruginosa lung infections, where both a pronounced antibody response and a skewed Th1/Th2 balance has been related to a poorer outcome. In addition, detection of an adaptive immune response can be used as a significant indicator of a chronic P. aeruginosa lung infection and is included in the clinical definitions as such. Those issues are presented in the present review, along with a characterization of the airway structure in relation to immune responses towards P. aeruginosa pulmonary infections.",
keywords = "biofilms, immunology, inflammation, lung infection, Pseudomonas aeruginosa",
author = "Kim Thomsen and Niels H{\o}iby and Jensen, {Peter {\O}strup} and Oana Ciofu and Claus Moser",
note = "Publisher Copyright: {\textcopyright} 2022 by the authors.",
year = "2022",
doi = "10.3390/biomedicines10092064",
language = "English",
volume = "10",
journal = "Biomedicines",
issn = "2227-9059",
publisher = "MDPI AG",
number = "9",

}

RIS

TY - JOUR

T1 - Immune Response to Biofilm Growing Pulmonary Pseudomonas aeruginosa Infection

AU - Thomsen, Kim

AU - Høiby, Niels

AU - Jensen, Peter Østrup

AU - Ciofu, Oana

AU - Moser, Claus

N1 - Publisher Copyright: © 2022 by the authors.

PY - 2022

Y1 - 2022

N2 - Biofilm infections are tolerant to the host responses and recalcitrance to antibiotic drugs and disinfectants. The induced host-specific innate and adaptive immune responses by established biofilms are significantly implicated and contributes to the course of the infections. Essentially, the host response may be the single one factor impacting the outcome most, especially in cases where the biofilm is caused by low virulent opportunistic bacterial species. Due to the chronicity of biofilm infections, activation of the adaptive immune response mechanisms is frequently experienced, and instead of clearing the infection, the adaptive response adds to the pathogenesis. To a high degree, this has been reported for chronic Pseudomonas aeruginosa lung infections, where both a pronounced antibody response and a skewed Th1/Th2 balance has been related to a poorer outcome. In addition, detection of an adaptive immune response can be used as a significant indicator of a chronic P. aeruginosa lung infection and is included in the clinical definitions as such. Those issues are presented in the present review, along with a characterization of the airway structure in relation to immune responses towards P. aeruginosa pulmonary infections.

AB - Biofilm infections are tolerant to the host responses and recalcitrance to antibiotic drugs and disinfectants. The induced host-specific innate and adaptive immune responses by established biofilms are significantly implicated and contributes to the course of the infections. Essentially, the host response may be the single one factor impacting the outcome most, especially in cases where the biofilm is caused by low virulent opportunistic bacterial species. Due to the chronicity of biofilm infections, activation of the adaptive immune response mechanisms is frequently experienced, and instead of clearing the infection, the adaptive response adds to the pathogenesis. To a high degree, this has been reported for chronic Pseudomonas aeruginosa lung infections, where both a pronounced antibody response and a skewed Th1/Th2 balance has been related to a poorer outcome. In addition, detection of an adaptive immune response can be used as a significant indicator of a chronic P. aeruginosa lung infection and is included in the clinical definitions as such. Those issues are presented in the present review, along with a characterization of the airway structure in relation to immune responses towards P. aeruginosa pulmonary infections.

KW - biofilms

KW - immunology

KW - inflammation

KW - lung infection

KW - Pseudomonas aeruginosa

U2 - 10.3390/biomedicines10092064

DO - 10.3390/biomedicines10092064

M3 - Review

C2 - 36140163

AN - SCOPUS:85138615418

VL - 10

JO - Biomedicines

JF - Biomedicines

SN - 2227-9059

IS - 9

M1 - 2064

ER -

ID: 323856123